Rootz Communications Details Creative Approach Behind Pfizer's RSV Vaccine Campaign

Rootz Communications is claiming credit for creative work behind Pfizer's RSV vaccine campaign, according to a post published to the agency's LinkedIn page on August 4, 2026.

The post describes a creative approach built around balancing hope with honesty in the vaccine messaging. Rootz says the strategy drove higher engagement, though the post does not specify metrics, platforms, or a campaign name.

No additional details on media spend, flight dates, or creative assets were included in the announcement. Pfizer has not issued a separate statement confirming Rootz's role on the account.

The post positions Rootz as the agency behind the Pfizer advertising campaign, part of the broader body of advertising work tied to the company's vaccine portfolio. Pfizer's RSV vaccine, marketed as Abrysvo, has been a focus of the company's consumer health messaging since its 2023 approval.

Rootz Communications has not disclosed additional Pfizer assignments or the length of the relationship. The agency's LinkedIn page lists healthcare and pharmaceutical communications among its service areas, though a full client roster was not available at time of publication.

Free Agency Media has not independently verified the engagement figures referenced in the post. The claim is based solely on Rootz Communications' own account of the work, published without third-party confirmation.

This is a developing signal. Free Agency Media will update this post if Pfizer, Rootz, or a verified media buyer confirms additional details on the campaign's scope, timing, or performance.